Announcements Trials
Browse Landscape

Phase

Phase 2 11Phase 1/2 5Phase 1 3Phase NA 2Phase 3 1

Status

Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 66Gynecologic 5Genitourinary 4Thoracic 3Dermatologic 3Sarcoma 2Head & Neck 2Gastrointestinal 2CNS 2Other hematologic neoplasm 1Myeloid 1

Conditions

Brain Neoplasms 484Glioma 227Glioblastoma 223Neoplasms 62Neuroblastoma 56Central Nervous System Neoplasms 56Breast Neoplasms 54Meningioma 48Astrocytoma 42Neuroma, Acoustic 38Spinal Cord Neoplasms 35Neurofibromatosis 1 32Sarcoma 29Lung Neoplasms 29Oligodendroglioma 28Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Lymphoma 27Neoplasm Metastasis 26Head and Neck Neoplasms 25Melanoma 22Lymphoma, Non-Hodgkin 22Leukemia 22Meningeal Carcinomatosis 21Medulloblastoma 21Hodgkin Disease 21Burkitt Lymphoma 20Testicular Neoplasms 19Lymphoma, Follicular 19Multiple Myeloma 18Gliosarcoma 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase NA × Triple Negative Breast Neoplasms × CNS × Clear all
NCT03881605 2025-01-20

SYMPToM

Sunnybrook Health Sciences Centre

Phase NA Active not recruiting
50 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

NCT02448576 2017-06-01

PCI in Advanced Triple Negative Breast Cancer Patients Who Response to 1st Line Chemotherapy

Sun Yat-sen University

Phase NA Unknown
326 enrolled
BreastCNS

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡